IL157662A0 - N-but-3-enyl norbuprenorphine and its use as analgesic - Google Patents

N-but-3-enyl norbuprenorphine and its use as analgesic

Info

Publication number
IL157662A0
IL157662A0 IL15766202A IL15766202A IL157662A0 IL 157662 A0 IL157662 A0 IL 157662A0 IL 15766202 A IL15766202 A IL 15766202A IL 15766202 A IL15766202 A IL 15766202A IL 157662 A0 IL157662 A0 IL 157662A0
Authority
IL
Israel
Prior art keywords
norbuprenorphine
enyl
analgesic
enyl norbuprenorphine
Prior art date
Application number
IL15766202A
Other languages
English (en)
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL157662A0 publication Critical patent/IL157662A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15766202A 2001-03-02 2002-03-04 N-but-3-enyl norbuprenorphine and its use as analgesic IL157662A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27281901P 2001-03-02 2001-03-02
PCT/US2002/006766 WO2002070524A2 (en) 2001-03-02 2002-03-04 N-but-3-enyl norbuprenorphine and its use as analgesic

Publications (1)

Publication Number Publication Date
IL157662A0 true IL157662A0 (en) 2004-03-28

Family

ID=23041438

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15766202A IL157662A0 (en) 2001-03-02 2002-03-04 N-but-3-enyl norbuprenorphine and its use as analgesic

Country Status (14)

Country Link
US (2) US7125884B2 (xx)
EP (1) EP1368356A2 (xx)
JP (1) JP2004538256A (xx)
KR (1) KR20030088445A (xx)
CN (1) CN1507448A (xx)
BR (1) BR0207978A (xx)
CA (1) CA2439859A1 (xx)
IL (1) IL157662A0 (xx)
MX (1) MXPA03007885A (xx)
NO (1) NO20033854L (xx)
NZ (1) NZ528241A (xx)
RU (1) RU2003129531A (xx)
WO (1) WO2002070524A2 (xx)
ZA (1) ZA200307337B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
DK2326651T3 (da) * 2008-07-30 2014-01-20 Purdue Pharma Lp Buprenorphinanaloger
WO2012038813A1 (en) 2010-09-21 2012-03-29 Purdue Pharma L.P. Buprenorphine analogs
US9096606B2 (en) 2011-12-08 2015-08-04 Purdue Pharma, L.P. Quarternized buprenorphine analogs
RU2503678C1 (ru) * 2012-08-21 2014-01-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) 7α-(1-ГИДРОКСИ-2,2,2-ТРИФТОРЭТИЛ)-17-МЕТИЛ-3,6-ДИМЕТОКСИ-4,5α-ЭПОКСИ-6α,14αЭТЕНОИЗОМОРФИНАН И СПОСОБ ЕГО ПОЛУЧЕНИЯ
RU2506265C1 (ru) * 2012-08-21 2014-02-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Фторсодержащие производные тевинола и орвинола и способы их получения (варианты)
US10138207B2 (en) 2012-11-09 2018-11-27 Purdue Pharma, L.P. Benzomorphan analogs and the use thereof
JP6317755B2 (ja) 2012-12-07 2018-04-25 パーデュー、ファーマ、リミテッド、パートナーシップ オピオイド受容体モジュレーターとしてのブプレノルフィン類似体
CA2896202A1 (en) * 2012-12-28 2014-07-03 Purdue Pharma L.P. Substituted morphinans and the use thereof
US9056836B2 (en) 2013-01-31 2015-06-16 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
CA2934913A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Ring-contracted morphinans and the use thereof
US9988392B2 (en) 2013-12-26 2018-06-05 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
EP3087073B1 (en) 2013-12-26 2018-07-04 Purdue Pharma LP 10-substituted morphinan hydantoins
EP3086790A4 (en) 2013-12-27 2017-07-19 Purdue Pharma LP 6-substituted and 7-substituted morphinan analogs and the use thereof
JP2017521373A (ja) 2014-05-27 2017-08-03 パーデュー、ファーマ、リミテッド、パートナーシップ スピロ環モルフィナン及びその使用
MA40171A (fr) 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés d'azamophinan et leur utilisation
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP2002501923A (ja) 1998-01-29 2002-01-22 モナシュ ユニバーシティ 治療用化合物

Also Published As

Publication number Publication date
US20050192308A1 (en) 2005-09-01
US7125884B2 (en) 2006-10-24
WO2002070524A2 (en) 2002-09-12
MXPA03007885A (es) 2004-05-24
EP1368356A2 (en) 2003-12-10
CA2439859A1 (en) 2002-09-12
NZ528241A (en) 2004-08-27
KR20030088445A (ko) 2003-11-19
ZA200307337B (en) 2004-12-20
CN1507448A (zh) 2004-06-23
NO20033854D0 (no) 2003-09-01
BR0207978A (pt) 2004-03-02
WO2002070524A3 (en) 2002-10-17
US20040087605A1 (en) 2004-05-06
JP2004538256A (ja) 2004-12-24
RU2003129531A (ru) 2005-04-10
NO20033854L (no) 2003-10-28

Similar Documents

Publication Publication Date Title
IL157662A0 (en) N-but-3-enyl norbuprenorphine and its use as analgesic
AU2003296954A8 (en) Analgesic combination comprising nalbuphine
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
TW510372U (en) Afforesting and landscaping device
PL363657A1 (en) Foam inhibiting preparation and its application
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
EP1469860A4 (en) ANTICANCER COMBINATION AND USE THEREOF
GB0220214D0 (en) Compounds and their use
AU2003296369A8 (en) Imminoamines and preparation thereof
EP1407771A4 (en) SOPHORIDINE AND ITS USE AS ANALYZIC
EP1367123A4 (en) NEUROTONIN AND ITS USE
GB0230134D0 (en) Compounds and their use
GB2377179B (en) Magnotherapy device and use thereof
GB0218031D0 (en) Compounds and their use
GB0230281D0 (en) Compounds and their use
GB0220215D0 (en) Compounds and their use
AU2002327340A1 (en) 3-pyridylether rerivatives and their use as analgesics
GB2384433B (en) Magnotherapy device and use thereof
IL143163A0 (en) Electronic-mechanical-optical device and a way to use it
GB0211382D0 (en) Magnotherapy device and use thereof
GB0230066D0 (en) Compounds and their use
GB0227904D0 (en) Compounds and their use
GB0227905D0 (en) Compounds and their use
GB0230067D0 (en) Compounds and their use
GB0226752D0 (en) Compounds and their use